CD4 and rheumatoid arthritis: The use of this type of CAR-T cells in experiments in the B6.DR1 mouse model showed a reduction in the severity of RA disease as well as a CII-specific autoimmune CD4+ T cell response, demonstrating the high potential of this approach for the treatment of RA [121].